The Fourth China Innovative Drug Forum was successfully held on the morning of October 17, 2020. The forum focuses on the exchange and discussion on the basic ideas of innovative drug R & D in China, such as policies, strategies, scientific laws, risk control and internationalization strategies, and shares and exchanges on the international new progress and prospect prospects of innovative drug R & D. Leaders and experts attending the forum included Director Jiao Hong of China Food and Drug Administration, Yin Yong, Vice Mayor of Beijing, Chairman Liu Jingzhen of China Pharmaceutical Group Co., Ltd., Academician Chen Kaixian of Chinese Academy of Sciences and President Li Bo of National Institutes for Food and Drug Control. In addition, more than 100 editorial board members of Chinese Journal of New Drugs, more than 500 hospitals and enterprise experts and scholars attended the meeting. Dr. Gu Zheming, General Manager of Jiangsu Wanluo Medicine and Chief Drug Metabolism Expert of Yidu Zhengkang, was invited to give keynote report and participate in round-table discussion!

China has a large population of hypertensive patients, currently exceeding 270 million yuan. In 2013, the direct economic burden caused by hypertension reached 210.3 billion yuan, accounting for 6.61% of the total health costs in China. It causes a huge national medical burden.
According to the 2018 Revision of Chinese Guidelines for the Prevention and Treatment of Hypertension, the important risk factors of hypertension in Chinese population mainly include: high sodium, low potassium diet, overweight and obesity, excessive drinking, long-term mental stress and age, family history of hypertension, physical inactivity, diabetes, dyslipidemia and other causes.

In October, the "2020 Fourth China Forum on Innovative Drugs and Editorial Board of China Journal of New Drugs" sponsored by China Journal of New Drugs will be held in Beijing Yichuang International Convention and Exhibition Center. As a co-organizer, Yeedozencom sincerely invites you to attend the event (October 16-18, 2020)!